Skip to main content
Caplight Logo









Biosortia Microbiomics

Biosortia Microbiomics

Private
Dublin, OhioHealthcare & Life Scienceshttps://biosortia.com/

Last Round

Series A

Nov 1, 2012

Total Funding Raised

$10M

Company Overview

Biosortia Microbiomics is a drug discovery company that utilizes its proprietary Industrial-Scale Microbiome Mining (ISMM) platform to harvest and analyze microbial communities for novel small molecules.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Revenue Share, Government Contracts

AI Layer

Application

Keywords

drug discoverymicrobiome miningsmall molecule discoverynatural products discoveryAI for drug discoveryunculturable microbesbioprospectingnatural product librarymetagenomicsdrug discovery platformgenerative biologyAI-guided discoverymicrobiome databaseimmuno-oncologymetabolic diseasesobesity therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biosortia Microbiomics Comparables

Compare Biosortia Microbiomics with similar companies based on industry and business-model similarity.

Biosortia Microbiomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sirenas Marine Discovery
87%
Ginkgo Bioworks
80%
Artizan Biosciences
71%

Biosortia Microbiomics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 1, 2012
GrantOct 26, 2009

Key People

Founding team and executive leadership

Ross Youngs

CEO & Founder

Founding Team

Biosortia Microbiomics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2025

    Monthly visitors increased 44% MoM, reaching 1.2K.

  • May 4, 2025

    Monthly visitors grew 65% MoM, reaching 1.2K.

Biosortia Microbiomics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Biosortia Microbiomics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Biosortia Microbiomics's valuation, stock price, and market status.

Firmographic Details

HeadquartersDublin, Ohio
Employee Range10
Year Founded2012
Last FundingNov 1, 2012

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?